On Thursday, bluebird bio Inc (NASDAQ:BLUE)’s shares declined -4.54% to $121.25.
bluebird bio, Inc. ( BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and T cell-based immunotherapies, recently stated business highlights and financial results for the second quarter ended June 30, 2015.
Recent Highlights
SICKLE CELL DISEASE (SCD) AND BETA-THALASSEMIA DATA PRESENTATION AT THE 20TH CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION – Presented positive data from two patients with beta-thalassemia major and the first patient with severe sickle cell disease ever treated with our LentiGlobin BB305 product candidate. As of May 2015, Subjects 1201 and 1202 with beta-thalassemia major remained transfusion-independent for 16 and 14 months, respectively. Subject 1204 with severe SCD demonstrated increasing HbAT87Q production at six months’ follow-up and was free of transfusions for more than three months. At the six-month visit post-drug product infusion, the proportion of anti-sickling hemoglobin (HbAT87Q + HbF) in the patient with SCD accounted for 45 percent of all hemoglobin production. As of May 2015, the patient with SCD had no hospitalizations for sickle cell complications post-transplant, despite weaning of transfusions. LentiGlobin BB305 was well-tolerated, with no drug product-related adverse events observed as of the May 2015 data cut-off.
bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases. Its advanced product candidate is Lenti-D, which is in phase II/III clinical studies for the treatment of childhood cerebral adrenoleukodystrophy, a rare, hereditary neurological disorder affecting young boys; and LentiGlobin that is in phase I/II clinical studies for the treatment of beta-thalassemia major and severe sickle cell disease (SCD) in France, in addition to a phase I study in the United States for the treatment of severe SCD.
NetEase, Inc (ADR) (NASDAQ:NTES)’s shares dropped -1.92% to $119.73.
NetEase, Inc. (NTES) revealed a pipeline of new mobile game titles heading into closed beta testing, expanding on the company’s lineup of games for iPhone, iPad, iPod touch, and Android for potential release in western markets. Among those, action role-playing game Eternal Arena leads the plan with a closed beta program starting this week, with the action role-playing game Tome of the Sun and strategy role-playing game March of Heroes opening pre-registration for its forthcoming closed beta programs. To register for these programs, visit https://prereg.netease-na.com/.
NetEase, Inc., through its auxiliaries, operates an interactive online community in the People’s Republic of China. The company operates in three segments: Online Game Services; Advertising Services; and E-mail, E-commerce and Others. It offers massively multi-player online role-playing games and mobile games; and distributes its point cards to gamers across China, in addition to through wholesalers, Internet cafés, software stores, supermarkets, bookstores, newspaper stands, and convenience stores primarily in Guangzhou Province, Shanghai, and Beijing.
At the end of Thursday’s trade, McGraw Hill Financial Inc (NYSE:MHFI)‘s shares dipped -2.21% to $100.30.
McGraw Hill Financial, Inc. (MHFI) declared the pricing of its offering of $2.0 billion in aggregate principal amount of senior notes issued in three tranches with varying maturities as set forth below (collectively, the “Notes”).
- $400 million aggregate principal amount of 2.50% senior notes due 2018 (the “2018 Notes”)
- $700 million aggregate principal amount of 3.30% senior notes due 2020 (the “2020 Notes”)
- $900 million aggregate principal amount of 4.40% senior notes due 2026 (the “2026 Notes”)
The Notes were issued in a private placement transaction following Rule 144A and Regulation S under the Securities Act of 1933, as amended (the “Securities Act”).
Interest on the 2018 Notes and the 2026 Notes is payable semi-annually in cash in arrears on February 15 and August 15 of each year, starting on February 15, 2016. Interest on the 2020 Notes is payable semi-annually in cash in arrears on February 14 and August 14 of each year, startning on February 14, 2016. The Notes will be guaranteed by the Company’s partner Standard & Poor’s Financial Services LLC.
McGraw Hill Financial, Inc. provides benchmarks and ratings, analytics, data, and research services for the capital, commodities, and commercial markets worldwide. It operates in four segments: Standard & Poor’s Ratings Services (S&P Ratings), S&P Capital IQ, S&P Dow Jones Indices (S&P DJ Indices), and Commodities & Commercial (C&C). The S&P Ratings segment provides credit ratings, research, and analytics to the investors, corporations, governments, municipalities, commercial and investment banks, insurance companies, asset managers, and other debt issuers.
Energy Focus Inc (NASDAQ:EFOI), ended its Thursday’s trading session with 2.39% gain, and closed at $17.13.
Energy Focus Inc (NASDAQ:EFOI) declared financial results for the second quarter ended June 30, 2015.
Financial Highlights:
- Record net sales of $16.6 million represents 148.1 percent in year-over-year growth and 26.4 percent sequential growth from the first quarter of 2015.
- Gross margin of 45.9 percent represents 13.4 percentage points of improvement year-over-year, and is 4.8 percentage points higher than the first quarter of 2015.
- Operating income of $3.1 million represents a $3.6 million year-over-year enhance from an operating loss of $562 thousand in the second quarter of 2014, and a $1.8 million enhance from the first quarter of 2015.
- Net income of $2.1 million, or $0.21 per share, represents a $2.7 million year-over-year enhance from the preceding year’s second quarter loss, and a $1.0 million enhance from the first quarter of 2015.
Energy Focus, Inc. designs, develops, manufactures, markets, and installs energy-efficient lighting systems and solutions in the United States and internationally. It operates in two segments, Products and Solutions. The company offers commercial, industrial, government, and military and maritime energy-efficient light-emitting diode (LED) lighting offerings, counting LED luminares and fixtures to serve the United States Navy; tubular LED replacements for linear fluorescent lamps; LED luminares and fixtures; LED docklights; tubular LED parking garage luminares and fixtures; LED cold storage globe luminares; and LED retrofit kits for high-intensity discharge applications.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
